Safety, Tolerability, and the Body's Ability to Develop Resistance to an Investigational Vaccine for Shingles (V211-007)

NCT00109122 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Shingles

Interventions

BIOLOGICAL: zoster vaccine live (Oka/Merck)
BIOLOGICAL: Comparator: placebo (unspecified)

Sponsor

Merck Sharp & Dohme LLC